
21 Dec 2022
Results of Scheme Convening Hearing Amsterdam, Netherlands, 21 December 2022 19:45 CET: VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, and its subsidiary, VEON Holdings B.V. (the Company ), inform that, further to the announcement issued on 16 December 2022 regarding the Scheme Convening Hearing on 20 December 2022, the Court has today made an order (the Convening Order ) convening a single meeting of the Scheme Creditors of the 2023 Notes issued by the Company for the purpose of considering and, if thought fit, approving the Scheme in respect of the 2023 Notes (the Scheme Meeting ).
Further to the Convening Order, the Company has revised the terms of the Scheme to remove the Amendments in respect of the consent thresholds and quorum requirements under the 2023 Notes (as set out in paragraph 6.3(b) of the Practice Statement Letter dated 24 November 2022).
The Company has also today made available the Explanatory Statement, issued in connection with the Scheme in respect of the 2023 Notes, the Voting and Proxy Form and the Notice of Scheme Meeting, through the Scheme Website at deals.is.kroll.com/veon.
The Scheme Meeting will be held at 10.00 a.m. (London time) on 24 January 2023 (or such later time or date as the Company may decide and notify to Scheme Creditors) upon the Company being satisfied that it has obtained all necessary Authorisations for the Scheme Meeting to be held (including the OFAC Licence on terms that would authorise the Company to proceed with the Scheme Meeting). The Scheme Meeting will allow the Scheme Creditors to vote on the Scheme proposed by the Company in respect of its 2023 Notes, provided they are not precluded from doing so by law or regulation. To participate and vote at the Scheme Meeting, Scheme Creditors (or their DTC Participant on their behalf, as applicable) must have submitted validly completed Voting and Proxy Forms to Kroll Issuer Services Limited (as the Company's information agent) by the Voting Instruction Deadline (currently anticipated to be 5:00 p.m. (London time) on 19 January 2023).
Further information regarding the Scheme Meeting and submission of Voting and Proxy Forms will be provided by the Notice of Scheme Meeting and the Voting and Proxy Forms.
Capitalised terms used but not defined in this announcement have the meaning given to them in the Explanatory Statement.
Hard copies of the Explanatory Statement can be requested by Scheme Creditors from Kroll Issuer Services Limited (as the Company's information agent) by email to veon@is.kroll.com
About VEON
VEON is a NASDAQ and Euronext Amsterdam-listed global provider of connectivity and digital services. Our companies are transforming lifestyles through technology-driven services that empower opportunity in some of the world's fastest-growing emerging markets. For more information, visit: https://www.veon.com
Disclaimer
This release contains forward-looking statements, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, the potential benefits of the appointment described above. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events. Furthermore, elements of this release contain or may contain, inside information as defined under the Market Abuse Regulation (EU) No. 596/2014.
Contact information
VEON
Group Director Investor Relations
Nik Kershaw
bonds@veon.com
This website stores cookies on your computer. These cookies are used to improve vour website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy
We wont track your information when you visit our site. But in order to comply with your preferences, well have to use just one tiny cookie so that youre not asked to make this choice again.
AcceptDecline
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At IBC2026, MediaKind will make its first major appearance as a unified global powerhouse in video, showcasing one of the world's most comprehensive video i...
06/08/2026
Big Blue Marble (#5.A63) will demonstrate how its integrated technology and operational expertise help media companies scale premium services with less complexi...
06/08/2026
LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...
06/08/2026
LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...
06/08/2026
LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...
06/08/2026
LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....
06/08/2026
LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...
06/08/2026
Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...
06/08/2026
LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...
06/08/2026
LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...
06/08/2026
LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...
06/08/2026
Scripps Research's Skaggs Graduate School of Chemical and Biological Science...
06/08/2026
LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...
06/08/2026
LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...
06/08/2026
LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...
06/08/2026
LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...
06/08/2026
LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...
06/08/2026
LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...
06/08/2026
LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...
06/08/2026
LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...
06/08/2026
LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...
06/08/2026
LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Crowned with the 2006 Nobel Priz...
06/08/2026
LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...
06/08/2026
LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...
06/08/2026
LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...
06/08/2026
LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...
06/08/2026
LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...
06/08/2026
LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/08/2026
At this year's SET EXPO, PlayBox Neo will present recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solutions. By show...
06/08/2026
Live demo at IBC2026 VisualOn Booth, Hall 5, Stand A55
Amsterdam, Netherlands Modern Streaming Solutions Private Limited, a rising force in India's dig...
06/08/2026
Screen Australia and YouTube Australia fund five new teams through eleventh Skip...
06/08/2026
How Karukera Studio Built a Media Production Hub with SNS EVO
Melanie Ciotti August 5, 2026
0 Comments
Hero images displays Karukera Studio in Sainte-...
06/08/2026
NHK drama series Rosanjin no Kamado shot on PYXIS 6K
Brie Clayton August 5, 2026
0 Comments
Blackmagic PYXIS 6K and DaVinci Resolve Studio capture the...
06/08/2026
Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D
Jamie Cardoso August 5, 2026
0 Comments
If you do any kind of Architectural Vi...
06/08/2026
In Time airs Monday 10 August at 9.35pm on RT One and RT Player
In Time is the first film account of the life of D nal Lunny, one of the most influential Iri...
06/08/2026
Editor's note: This post is part of Into the Omniverse, a series focused on how developers, 3D practitioners and enterprises can transform their workflows u...
06/08/2026
August is here, bringing 26 new games for GeForce NOW members.
Command the seas in World of Warships: Legends and discover what's next in the GeForce NOW ...
05/08/2026
Thomson's Climate Crisis Toolkit for Media in Tanzania is being included in a new virtual library designed to ensure accurate and engaging storytelling arou...
05/08/2026
RSNs, teams, leagues, and streamers explore the present and future of local spor...
05/08/2026
As sports-production workflows generate larger volumes of unstructured data and ...